Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

SABCS 2009 /
Oral bisphosphonate and breast cancer: prospective results from the Women's Health Initiative (WHI)

9th - 13th Sep 2009

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 28.01.10
Views: 8080
Rating:

Dr Rowan Chlebowski - Harbor-University of California, Los Angeles

Oral bisphosphonates directly inhibit breast cancer incidence. Official San Antonio Breast Cancer Symposium press conference.

Watch Dr Chlebowski presenting his research into oestrogen and progestin therapy at the ASCO 2009 press conference.

Categories:

Breast SABCS 2009

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation